Thank you for reading this post, don't forget to subscribe!
March 30, 2026, 4:31 p.m. ET
Drug maker Novo Nordisk is cutting 400 jobs in Bloomington, amid signs that competition in the weight loss drug market has intensified.
A spokeswoman said in an email that the company would make the cuts in early May, after which about 1,400 local employees would remain.
“Despite this difficult decision, Novo Nordisk continues to invest in Site Bloomington as a critical part of our U.S. manufacturing network and our commitment to the people who depend on our medicines,” said Stacy Beard, public affairs and media relations principal.
Source link
